Myriad Genetics
MYGN
$22.76
Share price
1.34%
Change (1 day)
-1.47%
Change (1 year)
Market capitalization of Myriad Genetics (MYGN)
Market cap: $2.05 Billion
As of June 2024 Myriad Genetics has a market cap of $2.05 Billion. This makes Myriad Genetics the world's 4085th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Myriad Genetics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.05 B | 20.07% |
| 2023 | $1.71 B | 45.92% |
| 2022 | $1.17 B | -46.65% |
| 2021 | $2.20 B | 47.82% |
| 2020 | $1.49 B | -26.5% |
| 2019 | $2.02 B | -4.67% |
| 2018 | $2.12 B | -10.52% |
| 2017 | $2.37 B | 108.51% |
| 2016 | $1.14 B | -63.09% |
| 2015 | $3.09 B | 26.86% |
| 2014 | $2.43 B | 56.96% |
| 2013 | $1.55 B | -29.95% |
| 2012 | $2.21 B | 24.88% |
| 2011 | $1.77 B | -13.82% |
| 2010 | $2.05 B | -18.12% |
| 2009 | $2.51 B | -18.4% |
| 2008 | $3.08 B | 49.62% |
| 2007 | $2.05 B | 64.9% |
| 2006 | $1.24 B | 53.44% |
| 2005 | $0.81 B | 17.69% |
| 2004 | $0.69 B | 98.13% |
| 2003 | $0.34 B | -11.49% |
| 2002 | $0.39 B | -68.45% |
| 2001 | $1.25 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Myriad Genetics was reported to be:
$2.05 Billion
$2.05 Billion
$2.05 Billion
$2.05 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $177.77 B | 8,529.91% | 🇺🇸 USA |
 Exact Sciences EXAS | $8.38 B | 307.14% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.25 B | 591.97% | 🇺🇸 USA |
 Biocept
BIOC | $1.14 M | -99.94% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $8.17 B | 296.70% | 🇺🇸 USA |